Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
6.71
+0.22 (3.39%)
Apr 29, 2026, 12:11 PM EDT - Market open
Tevogen Bio Holdings Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 0.55 | 1.28 | 1.05 | 5.48 | 7.12 |
| Cash & Short-Term Investments | 0.55 | 1.28 | 1.05 | 5.48 | 7.12 |
| Cash Growth | -56.95% | 21.91% | -80.81% | -22.96% | - |
| Other Receivables | 0.16 | 0.16 | - | - | - |
| Receivables | 0.16 | 0.16 | - | - | - |
| Prepaid Expenses | 0.83 | 0.92 | 0.67 | 0.35 | 0.05 |
| Total Current Assets | 1.54 | 2.36 | 1.72 | 5.84 | 7.17 |
| Property, Plant & Equipment | 1.59 | 0.52 | 0.93 | 1.31 | 0.14 |
| Long-Term Deferred Charges | 0.18 | - | 2.58 | - | - |
| Other Long-Term Assets | 1.07 | 0.58 | 0.27 | 0.59 | 0.34 |
| Total Assets | 4.38 | 3.46 | 5.51 | 7.74 | 7.66 |
| Accounts Payable | 3.34 | 5.2 | 3.42 | 0.87 | 0.38 |
| Accrued Expenses | 1.42 | 1.56 | 0.98 | 0.58 | 0.24 |
| Short-Term Debt | 1.65 | 1.65 | - | - | - |
| Current Portion of Long-Term Debt | - | - | 80.71 | - | - |
| Current Portion of Leases | 0.33 | 0.23 | 0.25 | 0.28 | - |
| Other Current Liabilities | 0.33 | 0.4 | 0.12 | 0.24 | 0.05 |
| Total Current Liabilities | 7.07 | 9.04 | 85.48 | 1.96 | 0.67 |
| Long-Term Debt | 4.4 | 1 | 14.22 | 39.3 | 23.48 |
| Long-Term Leases | 1.12 | 0.01 | 0.23 | 0.43 | - |
| Other Long-Term Liabilities | 0.03 | 0.09 | - | - | - |
| Total Liabilities | 12.62 | 10.14 | 99.93 | 41.69 | 24.15 |
| Common Stock | 0 | 0 | 0.01 | 0.06 | 0.06 |
| Additional Paid-In Capital | 122.63 | 97.91 | 5.22 | 5.17 | 0.59 |
| Retained Earnings | -139.66 | -113.39 | -99.66 | -39.18 | -17.14 |
| Total Common Equity | -17.03 | -15.47 | -94.43 | -33.95 | -16.49 |
| Shareholders' Equity | -8.23 | -6.67 | -94.43 | -33.95 | -16.49 |
| Total Liabilities & Equity | 4.38 | 3.46 | 5.51 | 7.74 | 7.66 |
| Total Debt | 7.5 | 2.89 | 95.42 | 40.01 | 23.48 |
| Net Cash (Debt) | -6.95 | -1.6 | -94.37 | -34.52 | -16.36 |
| Net Cash Per Share | -2.09 | -0.55 | -190.63 | -68.35 | -32.62 |
| Filing Date Shares Outstanding | 4.16 | 3.68 | 3.29 | 24.75 | 0.5 |
| Total Common Shares Outstanding | 4.02 | 3.56 | 24.75 | 24.75 | 0.5 |
| Working Capital | -5.53 | -6.68 | -83.76 | 3.88 | 6.51 |
| Book Value Per Share | -4.24 | -4.35 | -3.81 | -1.37 | -32.87 |
| Tangible Book Value | -17.03 | -15.47 | -94.43 | -33.95 | -16.49 |
| Tangible Book Value Per Share | -4.24 | -4.35 | -3.81 | -1.37 | -32.87 |
| Machinery | 0.46 | 0.46 | 0.46 | 0.46 | 0.15 |
| Leasehold Improvements | 0.13 | 0.26 | 0.26 | 0.26 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.